Leading pharmaceutical companies are actively shaping the Kinrix market, with GlaxoSmithKline plc (GSK) standing out as a key player. As a multinational pharmaceutical company, GSK has played a ...

The Food and Drug Administration on Tuesday approved GSK’s drug for a common type of urinary tract infection (UTI) in women and adolescent girls, one of five new approvals the British drugmaker ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

21st Mar 2025 7:00 am RNS Transaction in Own Shares 20th Mar 2025 7:00 am RNS Transaction in Own Shares 19th Mar 2025 7:00 am RNS Transaction in Own Shares ...

3 Year 86.59% 86.61% 35.40% 37.37% ...

GlaxoSmithKline is investing in artificial intelligence (AI) with the hope of radically cutting the time and money needed to develop a drug. It has entered into an alliance with Exscientia, a new ...

GSK has filed a pair of lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and respiratory syncytial virus (RSV). According to court documents, the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...